Freek W.A. Verheugt

Predictors of Coronary Stent Thrombosis

Jochem W. van Werkum, Antonius A.C.M. Heestermans, Anoek Zomer et al. · Journal of the American College of Cardiology · 2009 · 685 citations

Long-term benefit of early thrombolytic therapy in patients with acute myocardial infarction: 5 year follow-up of a trial conducted by the Interuniversity Cardiology Institute of the Netherlands

Maarten L. Simoons, Jeroen Vos, Jan G.P. Tijssen et al. · Journal of the American College of Cardiology · 1989 · 220 citations

Thrombosis, Cardiovascular Disease, Long-term Benefit +7

Spironolactone in congestive heart failure refractory to high-dose loop diuretic and low-dose angiotensin-converting enzyme inhibitor

A. van Vliet, A. J. M. Donker, Jos J. P. Nauta et al. · The American Journal of Cardiology · 1993 · 171 citations

Hypertension, Heart Failure, Cardiovascular Disease +9

Long-Term Clinical Outcome After a First Angiographically Confirmed Coronary Stent Thrombosis

Jochem W. van Werkum, Antonius A.C.M. Heestermans, Fleur I. de Korte et al. · Circulation · 2009 · 164 citations

Abciximab in the treatment of acute myocardial infarction eligible for primary percutaneous transluminal coronary angioplasty

Lambert F.M van den Merkhof, Felix Zijlstra, Hans Olsson et al. · Journal of the American College of Cardiology · 1999 · 138 citations

Percutaneous Coronary Intervention, Cardiovascular Disease, Acute Myocardial Infarction +5